Genetic Correction of Human Induced Pluripotent Stem Cells from Patients with Spinal Muscular Atrophy

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Science Translational Medicine

• Publication date

  2012-12-19

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1126/scitranslmed.3004108PMID 23253609PMCID PMC4722730
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequences Human Induced Pluripotent Stem Cells Free of Vector and Transgene

  2012influential reference
• Impaired minor tri-snRNP assembly generates differential splicing defects of U12-type introns in lymphoblasts derived from a type I SMA patient.

  2011cited by this paper
• Tumorigenic Development of Induced Pluripotent Stem Cells in Ischemic Mouse Brain

  2011cited by this paper
• ALS pathogenesis: recent insights from genetics and mouse models.

  2011cited by this paper
• Intramyocardial Transplantation of Undifferentiated Rat Induced Pluripotent Stem Cells Causes Tumorigenesis in the Heart

  2011cited by this paper
• Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.

  2011cited by this paper
• Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN

  2011cited by this paper
• CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.

  2010cited by this paper
• Systemic Delivery of scAAV9 Expressing SMN Prolongs Survival in a Model of Spinal Muscular Atrophy

  2010cited by this paper
• Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN

  2010cited by this paper
• Embryonic stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice.

  2010influential reference
• Spinal muscular atrophy disease: a literature review for therapeutic strategies

  2010cited by this paper
• Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences

  2009cited by this paper
• Motoneuron Transplantation Rescues the Phenotype of SMARD1 (Spinal Muscular Atrophy with Respiratory Distress Type 1)

  2009cited by this paper
• Induced pluripotent stem cells from a spinal muscular atrophy patient

  2009cited by this paper
• A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis

  2009cited by this paper
• Highly Efficient Differentiation and Enrichment of Spinal Motor Neurons Derived from Human and Monkey Embryonic Stem Cells

  2009cited by this paper
• Differentiation of spinal motor neurons from pluripotent human stem cells

  2009cited by this paper
• Faculty Opinions recommendation of Human induced pluripotent stem cells free of vector and transgene sequences.

  2009cited by this paper
• Alternative Splicing Events Are a Late Feature of Pathology in a Mouse Model of Spinal Muscular Atrophy

  2009cited by this paper
• FIRMA: a method for detection of alternative splicing from exon array data

  2008cited by this paper
• SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing.

  2008cited by this paper
• Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy.

  2008influential reference
• Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons

  2008cited by this paper
• Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy.

  2008cited by this paper
• Generation of germline-competent induced pluripotent stem cells

  2007cited by this paper
• Mutant SOD1G93A microglia are more neurotoxic relative to wild‐type microglia

  2007cited by this paper
• Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

  2007cited by this paper
• Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.

  2007cited by this paper
• Optimized protocols for isolation of primary motor neurons, astrocytes and microglia from embryonic mouse spinal cord.

  2007cited by this paper
• Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

  2007cited by this paper
• SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN.

  2005cited by this paper
• Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse

  2005cited by this paper
• Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments

  2004cited by this paper
• Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy

  2004cited by this paper
• Summaries of Affymetrix GeneChip probe level data.

  2003cited by this paper
• Soma-Restricted Products of the Myelin Proteolipid Gene Are Expressed Primarily in Neurons in the Developing Mouse Nervous System

  2003cited by this paper
• Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

  2003cited by this paper
• The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.

  2000cited by this paper
• A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy.

  1999influential reference
• Stathmin and its phosphoprotein family: general properties, biochemical and functional interaction with tubulin.

  1999cited by this paper
• Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos.

  1997cited by this paper
• Correlation between severity and SMN protein level in spinal muscular atrophy

  1997cited by this paper
• The gene encoding p44, a subunit of the transcription factor TFIIH, is involved in large-scale deletions associated with Werdnig-Hoffmann disease.

  1997cited by this paper
• The survival motor neuron protein in spinal muscular atrophy.

  1997cited by this paper
• The neurobiology of childhood spinal muscular atrophy.

  1996cited by this paper
• PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy.

  1995cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper
• Identification and characterization of a spinal muscular atrophy-determining gene

  1995cited by this paper
• International SMA consortium meeting. (26-28 June 1992, Bonn, Germany).

  1992cited by this paper
• International SMA consortium meeting

  1992cited by this paper

• Targeted antisense oligonucleotide treatment rescues developmental alterations in spinal muscular atrophy organoids

  2025cites this paper
• Novel Translational Concept: Axon-to-Muscle Exosomal Signaling as an Emerging Therapeutic Target in Spinal Muscular Atrophy

  2025cites this paper
• Recent advances in stem cell approaches to neurodegeneration: A comprehensive review with mechanistic insight.

  2025cites this paper
• ADSL deficiency is a secondary mitochondrial disease affecting organelle homeostasis and ERK2/AKT signaling in a linear genotype-phenotype relation

  2025cites this paper
• Riboflavin transporter deficiency: AAV9-SLC52A2 gene therapy as a new therapeutic strategy

  2025cites this paper
• Current Applications of Human Pluripotent Stem Cells in Neuroscience Research and Cell Transplantation Therapy for Neurological Disorders

  2025cites this paper
• Isogenic patient-derived organoids reveal early neurodevelopmental defects in spinal muscular atrophy initiation

  2024cites this paper
• Caspase-dependent apoptosis in Riboflavin Transporter Deficiency iPSCs and derived motor neurons

  2024cites this paper
• Targeting STMN2 for neuroprotection and neuromuscular recovery in Spinal Muscular Atrophy: evidence from in vitro and in vivo SMA models

  2024influential citation
• Exploring Environmental Neurotoxicity Assessment Using Human Stem Cell-Derived Models

  2024cites this paper
• Modeling riboflavin transporter deficiency type 2: from iPSC-derived motoneurons to iPSC-derived astrocytes

  2024cites this paper
• Cerebral organoid research for pediatric patients with neurological disorders

  2024cites this paper
• Stem Cell-Based Therapeutic Approaches in Genetic Diseases.

  2023cites this paper
• Progress and challenges in directing the differentiation of human iPSCs into spinal motor neurons

  2023cites this paper
• Unlocking the Complexity of Neuromuscular Diseases: Insights from Human Pluripotent Stem Cell-Derived Neuromuscular Junctions

  2023cites this paper
• Transcription Factor-Mediated Differentiation of Motor Neurons from Human Pluripotent Stem Cells.

  2023cites this paper
• Spinal Cord Organoids to Study Motor Neuron Development and Disease

  2023cites this paper
• Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot–Marie–Tooth type 2A

  2023cites this paper
• Pluripotent stem cell strategies for rebuilding the human brain

  2022cites this paper
• Dominantly acting KIF5B variants with pleiotropic cellular consequences cause variable clinical phenotypes

  2022cites this paper
• Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets

  2022influential citation
• Single-cell RNA sequencing reveals dysregulation of spinal cord cell types in a severe spinal muscular atrophy mouse model

  2022cites this paper
• NSC Physiological Features in Spinal Muscular Atrophy: SMN Deficiency Effects on Neurogenesis

  2022cites this paper
• NOVA1 promotes SMN2 exon 7 splicing by binding the UCAC motif and increases SMN protein expression

  2022cites this paper
• Survival Motor Neuron Enhances Pluripotent Gene Expression and Facilitates Cell Reprogramming

  2022cites this paper
• History of development of the life-saving drug “Nusinersen” in spinal muscular atrophy

  2022cites this paper
• Motor neuron-derived induced pluripotent stem cells as a drug screening platform for amyotrophic lateral sclerosis

  2022cites this paper
• How induced pluripotent stem cells changed the research status of polycystic ovary syndrome

  2022cites this paper
• Molecular Pathogenesis and New Therapeutic Dimensions for Spinal Muscular Atrophy

  2022cites this paper
• Single-cell profiling of the human primary motor cortex in ALS and FTLD

  2021cites this paper
• Impairment of the neurotrophic signaling hub B-Raf contributes to motoneuron degeneration in spinal muscular atrophy

  2021cites this paper
• Stem Cell Models and Gene Targeting for Human Motor Neuron Diseases

  2021cites this paper
• System biology and bioinformatics pipeline to identify comorbidities risk association: Neurodegenerative disorder case study

  2021cites this paper
• Genome editing in stem cells for genetic neurodisorders.

  2021cites this paper
• Nisin and non-essential amino acids: new perspective in differentiation of neural progenitors from human-induced pluripotent stem cells in vitro

  2021cites this paper
• The path to progress preclinical studies of age-related neurodegenerative diseases: A perspective on rodent and hiPSC-derived models.

  2021cites this paper
• Current Progress in the Creation, Characterization, and Application of Human Stem Cell-derived in Vitro Neuromuscular Junction Models

  2021cites this paper
• Connecting TDP-43 Pathology with Neuropathy.

  2021cites this paper
• Novel genome-editing-based approaches to treat motor neuron diseases: Promises and challenges

  2021influential citation
• Induced pluripotent stem cells for modeling of spinal muscular atrophy

  2021cites this paper
• NOVA1 Promotes SMN2 Exon 7 Splicing via Binding the UCAC Motif and Increases SMN Protein Expression

  2021cites this paper
• Cell Transdifferentiation and Reprogramming in Disease Modeling: Insights into the Neuronal and Cardiac Disease Models and Current Translational Strategies

  2021cites this paper
• Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies.

  2020cites this paper
• Prenatal transplantation of human amniotic fluid stem cell could improve clinical outcome of type III spinal muscular atrophy in mice

  2020cites this paper
• Cell-Based Therapy for Spinal Muscular Atrophy.

  2020cites this paper
• Stem Cell-based Therapy for Neurodegenerative Diseases

  2020influential citation
• Therapeutic potential of stem cells for treatment of neurodegenerative diseases

  2020cites this paper
• Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1)

  2020cites this paper
• Neural In Vitro Models for Studying Substances Acting on the Central Nervous System.

  2020cites this paper
• Neural induction of embryonic stem/induced pluripotent stem cells

  2020cites this paper
• Synaptotagmin 13 is neuroprotective across motor neuron diseases

  2020cites this paper
• Glial cells involvement in spinal muscular atrophy: Could SMA be a neuroinflammatory disease?

  2020cites this paper
• LCM-seq reveals unique transcriptional adaptation mechanisms of resistant neurons and identifies protective pathways in spinal muscular atrophy

  2020cites this paper
• Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies

  2019cites this paper
• Spinal Muscular Atrophy and Common Therapeutic Advances

  2019cites this paper
• Genome Editing for Duchenne Muscular Dystrophy

  2019cites this paper
• Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons

  2019cites this paper
• Organs to Cells and Cells to Organoids: The Evolution of in vitro Central Nervous System Modelling

  2019cites this paper
• A SMN2 Splicing Modifier Rescues the Disease Phenotypes in an In Vitro Human Spinal Muscular Atrophy Model

  2019cites this paper
• Delineating Common Cell Pathways that Influence Type 2 Diabetes and Neurodegenerative Diseases using a Network-based Approach

  2019cites this paper
• In vitro models of neuromuscular junctions and their potential for novel drug discovery and development

  2019cites this paper
• Modeling rare pediatric neurogenetic disorders with IPSCs

  2019cites this paper
• Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons

  2019cites this paper
• CSF transplantation of a specific iPSC-derived neural stem cell subpopulation ameliorates the disease phenotype in a mouse model of spinal muscular atrophy with respiratory distress type 1.

  2019cites this paper
• Investigations of Microtubule-associated Protein 2 Gene Expression in Spinal Muscular Atrophy

  2019influential citation
• Hyperexcitability precedes motoneuron loss in the Smn2B/-mouse model of spinal muscular atrophy.

  2019cites this paper
• Spinal Muscular Atrophy Modeling and Treatment Advances by Induced Pluripotent Stem Cells Studies

  2019cites this paper
• LCM-seq reveals unique transcriptional adaption mechanisms of resistant neurons in spinal muscular atrophy

  2018cites this paper
• Modeling the Brain in the Culture Dish: Advancements and Applications of Induced Pluripotent Stem‐Cell‐Derived Neurons

  2018cites this paper
• Advances in spinal muscular atrophy therapeutics

  2018cites this paper
• Biofabrication of Three-Dimensional Neural Tissue Constructs from Human Induced Pluripotent Stem Cells

  2018cites this paper
• Seamless Genetic Conversion of SMN2 to SMN1 via CRISPR/Cpf1 and Single-Stranded Oligodeoxynucleotides in Spinal Muscular Atrophy Patient-Specific Induced Pluripotent Stem Cells

  2018influential citation
• Neonatal mouse cortical but not isogenic human astrocyte feeder layers enhance the functional maturation of induced pluripotent stem cell‐derived neurons in culture

  2018cites this paper
• MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors

  2018cites this paper
• Investigating Pediatric Disorders with Induced Pluripotent Stem Cells

  2018cites this paper
• Prenatal transplantation of human amniotic fluid stem cells for spinal muscular atrophy

  2018cites this paper
• Modeling neuromuscular junctions in vitro : A review of the current progress employing human induced pluripotent stem cells

  2018cites this paper
• Spinal muscular atrophy.

  2018cites this paper
• Harnessing cellular aging in human stem cell models of amyotrophic lateral sclerosis

  2018cites this paper
• Evaluating Cell Identity from Transcription Profiles

  2018influential citation
• Modeling the differential phenotypes of spinal muscular atrophy with high-yield generation of motor neurons from human induced pluripotent stem cells

  2017cites this paper
• COMPUTATIONAL APPROACHES IN THE ESTIMATION AND ANALYSIS OF TRANSCRIPTS DIFFERENTIAL EXPRESSION AND SPLICING: APPLICATION TO SPINAL MUSCULAR ATROPHY

  2017cites this paper
• Addressing Cell Therapy for Spinal Muscular Atrophy: Open Issues and Future Perspectives

  2017cites this paper
• miRNA in spinal muscular atrophy pathogenesis and therapy

  2017cites this paper
• Cellular Therapy for Spinal Muscular Atrophy: Pearls and Pitfalls

  2017cites this paper
• MOTOR NEURON DISEASES

  2017influential citation
• A step forward in disease modelling for mitochondrial diseases.

  2017cites this paper
• Self-Organized Cerebellar Tissue from Human Pluripotent Stem Cells and Its Application to Clinical Medicine

  2017cites this paper
• Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown–Vialetto disease that is partially rescued by riboflavin

  2017cites this paper
• Spinal Muscular Atrophy Therapeutics Development

  2017cites this paper
• Cell Reprogramming for Cardiac Regeneration and Rare Disease Modeling

  2017cites this paper
• CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs

  2017cites this paper
• Modeling the phenotype of spinal muscular atrophy by the direct conversion of human fibroblasts to motor neurons

  2017cites this paper
• Cell Culture Models of Spinal Muscular Atrophy

  2017cites this paper
• Therapeutic opportunities and challenges of induced pluripotent stem cells-derived motor neurons for treatment of amyotrophic lateral sclerosis and motor neuron disease

  2017influential citation
• Genome engineering: a new approach to gene therapy for neuromuscular disorders

  2017cites this paper
• Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease

  2017cites this paper
• Neuroprotection As a Therapeutic Approach for Spinal Muscular Atrophy

  2017cites this paper
• Posibilidades de tratamiento en la atrofia espinal infantil

  2017cites this paper
• Prostaglandin E2 facilitates neurite outgrowth in a motor neuron-like cell line, NSC-34.

  2017cites this paper